Javascript must be enabled to continue!
Abstract 1502: DCLK1 labeling a unique pancreatic cellular lineage contributes to intraductal papillary mucinous neoplasm development
View through CrossRef
Abstract
BACKGROUND & AIMS: Recently DCLK1 has been controversial as a biomarker of progenitor cells in both intestinal tract and pancreas. Pancreatic intraductal papillary mucinous neoplasm (IPMN), in contrast to pancreatic intraepithelial neoplasia (PanIN), has been relatively less investigated. Here, we explored whether DCLK1-expressing cells were involved in the genesis of pancreatic IPMNs using mouse models. METHODS: We compared the incidence of DCLK1-positive cells in pancreatic tissue samples derived from mouse models for IPMNs, PanINs, acinar to ductal metaplasia (ADM), and human IPMN samples by immunohistochemistry. And how the DCLK1+ cells engage ADM and IPMNs and its origin were investigated by in vitro culture and in vivo lineage tracing. RESULTS: The DCLK1+ cells were identified exclusively in the pancreatic tissues with activated oncogene compared to wild-type. Mouse lineage tracing experiments showed that DCLK1+ cells might originate from a cell lineage distinct from pancreatic PDX1 (+) progenitors. The pancreatic DCLK1+ cells shared the features of tuft cells but absence of IPMN tumor biomarkers. DCLK1+ cells presented in the acinar clusters prior to formation of metaplastic ductal cells, and enriched in the “IPMN niches”. Oncogenic signaling pathways such as SHH and DLL4 were activated or upregulated in the tumor cells but not the DCLK1+ cells of IPMNs. DCLK1 was also expressed in a subpopulation of tumor cells in 20% of human IPMN patients. CONCLUSIONS: DCLK1 labels a unique pancreatic cellular lineage in mouse. The clustering of DCLK1+ cells is an early event in oncogene-induced tumorigenesis. Pancreatic DCLK1+ cells may contribute to the initiation of ADM and its progression to IPMNs.
Key words: Pancreatic IPMN; ADM; DCLK1; SOX9.
Citation Format: Wanglong Qiu, Gloria Su. DCLK1 labeling a unique pancreatic cellular lineage contributes to intraductal papillary mucinous neoplasm development. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 1502. doi:10.1158/1538-7445.AM2015-1502
Title: Abstract 1502: DCLK1 labeling a unique pancreatic cellular lineage contributes to intraductal papillary mucinous neoplasm development
Description:
Abstract
BACKGROUND & AIMS: Recently DCLK1 has been controversial as a biomarker of progenitor cells in both intestinal tract and pancreas.
Pancreatic intraductal papillary mucinous neoplasm (IPMN), in contrast to pancreatic intraepithelial neoplasia (PanIN), has been relatively less investigated.
Here, we explored whether DCLK1-expressing cells were involved in the genesis of pancreatic IPMNs using mouse models.
METHODS: We compared the incidence of DCLK1-positive cells in pancreatic tissue samples derived from mouse models for IPMNs, PanINs, acinar to ductal metaplasia (ADM), and human IPMN samples by immunohistochemistry.
And how the DCLK1+ cells engage ADM and IPMNs and its origin were investigated by in vitro culture and in vivo lineage tracing.
RESULTS: The DCLK1+ cells were identified exclusively in the pancreatic tissues with activated oncogene compared to wild-type.
Mouse lineage tracing experiments showed that DCLK1+ cells might originate from a cell lineage distinct from pancreatic PDX1 (+) progenitors.
The pancreatic DCLK1+ cells shared the features of tuft cells but absence of IPMN tumor biomarkers.
DCLK1+ cells presented in the acinar clusters prior to formation of metaplastic ductal cells, and enriched in the “IPMN niches”.
Oncogenic signaling pathways such as SHH and DLL4 were activated or upregulated in the tumor cells but not the DCLK1+ cells of IPMNs.
DCLK1 was also expressed in a subpopulation of tumor cells in 20% of human IPMN patients.
CONCLUSIONS: DCLK1 labels a unique pancreatic cellular lineage in mouse.
The clustering of DCLK1+ cells is an early event in oncogene-induced tumorigenesis.
Pancreatic DCLK1+ cells may contribute to the initiation of ADM and its progression to IPMNs.
Key words: Pancreatic IPMN; ADM; DCLK1; SOX9.
Citation Format: Wanglong Qiu, Gloria Su.
DCLK1 labeling a unique pancreatic cellular lineage contributes to intraductal papillary mucinous neoplasm development.
[abstract].
In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA.
Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 1502.
doi:10.
1158/1538-7445.
AM2015-1502.
Related Results
Pancreatic cystic tumors: an update
Pancreatic cystic tumors: an update
Abstract
Pancreatic cystic tumors (PCTs) comprise a heterogeneous group of entities, accounting for 2% to 10% of pancreatic lesions. The most common types are intraduct...
CYTOLOGICAL CRITERIA OF PANCREATIC JUICE IN INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS
CYTOLOGICAL CRITERIA OF PANCREATIC JUICE IN INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS
Although it is not always easy to distinguish benign from malignant intraductal papillary mucinous neoplasms of the pancreas by the imaging techniques, the cytological examination ...
Cystic Lesion Mimicking Intraductal Papillary Mucinous Tumor Arising in Heterotopic Pancreas of the Stomach and Synchronous Intraductal Papillary Mucinous Adenocarcinoma of the Pancreas
Cystic Lesion Mimicking Intraductal Papillary Mucinous Tumor Arising in Heterotopic Pancreas of the Stomach and Synchronous Intraductal Papillary Mucinous Adenocarcinoma of the Pancreas
This article presents the study of a 66-year-old man with an asymptomatic pancreatic mass detected incidentally 4 months earlier. A magnetic resonance imaging scan revealed 2 disti...
Molecular pathology of pancreatic cancer
Molecular pathology of pancreatic cancer
By genomic and epigenomic screening techniques, substantial progress has been made in our understanding of pancreatic cancer. The comprehensive studies of the pancreatic cancer gen...
High Expression of AMIGO2 Is an Independent Predictor of Poor Prognosis in Pancreatic Cancer
High Expression of AMIGO2 Is an Independent Predictor of Poor Prognosis in Pancreatic Cancer
Abstract
Background.The AMIGO2 extracellular domain has a leucine - rich repetitive domain (LRR) and encodes a type 1 transmembrane protein , and is a member of the AMIGO g...
Clinicopathological Features of Indeterminate Thyroid Nodules: A Single-center Cross-sectional Study
Clinicopathological Features of Indeterminate Thyroid Nodules: A Single-center Cross-sectional Study
Abstract
Introduction
Due to indeterminate cytology, Bethesda III is the most controversial category within the Bethesda System for Reporting Thyroid Cytopathology. This study exam...
Elevated Serum Lipase Levels as a Marker of Intraductal Papillary Mucinous Neoplasm of the Pancreas: A Cross-Sectional Study
Elevated Serum Lipase Levels as a Marker of Intraductal Papillary Mucinous Neoplasm of the Pancreas: A Cross-Sectional Study
Abstract
Background: Intraductal papillary mucinous neoplasm (IPMN) is a well-established premalignant pancreatic lesion. It is known that mild hyperlipasemia, elevated ser...
Abstract A044: Persistence of fetal splanchnic gene signature defines a tumor-restraining fibroblast subtype in pancreatic cancer
Abstract A044: Persistence of fetal splanchnic gene signature defines a tumor-restraining fibroblast subtype in pancreatic cancer
Abstract
The pancreas is composed of the epithelial and mesenchymal cells. While mesenchymal fibroblasts are a minor component of the normal pancreas, fibroblast pop...

